Skip to content

The influence of kefir consumption on the intestinal microbiome of healthy adults – a pilot study

The influence of kefir consumption on the intestinal microbiome of healthy adults – a pilot study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621001558819
Enrollment
18
Registered
2021-11-17
Start date
2022-10-04
Completion date
2023-09-07
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The human digestive tract, especially the gut, is populated by millions of microorganisms including bacteria, and fungi, the so-called microbiome. Many studies have shown that the microbiome is linked to health from digestive disorders, to heart health, or mental health. The microbiome can be modified by your diet, and probiotics are frequently advertised to alter the gut microbiome. One such product is kefir, a probiotic dairy beverage that has been consumed for over 2,000 years. Traditional kefir is produced by taking for example cow’s milk, and adding Kefir ‘grains’ which contain a diverse range of symbiotic bacteria and yeast species. Anecdotal statements in the media continue to link the consumption of Kefir to gut health, despite a lack of scientific evidence to support this. In order to advance the scientific understanding of Kefir, this study aims to examine whether kefir consumption leads to changes in the oral and gut microbiome, i.e. the bacteria living in the digestive tract. It is hypothesised, that kefir will increase the number of beneficial bacteria in the mouth and gut.

Interventions

Commercially available kefir drink based on fermented full-cream cow milk. The kefir has no thickeners/gels and is made with unhomogenised fresh milk from free range pasture fed cows. Participants take the kefir at home, 200ml per day in total, taken twice daily (100ml in the morning, 100ml in the evening) The intervention is for 14 days in total, and consumption will be monitored via a diary, in which participants indicate whether they have used the intervention as directed

Sponsors

Southern Cross University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy BMI 18.5-29.9

Exclusion criteria

- Acute illness (injury, infection) - Chronic gastrointestinal conditions (inflammatory or functional bowel diseases, celiac disease, food intolerance or allergies (especially milk), lactose intolerance - Use of long-term medication - Use of antimicrobial medication (incl. antibiotics) in the previous 6 months - Regular use of pre-, pro-, or synbiotics in the previous 6 months, specifically natural yogurt, probiotic drinks, or products (at least once weekly) - Consumption of fermented foods for health purpose within the last 2 months, specifically kefir, sauerkraut, kombucha, miso, kimchi (occasional consumption is acceptable) - Diet prescribed for medical purposes - Recent lifestyle changes (including new dietary regimen, or uptake of exercise regimen) - Women currently undergoing menopause, and women who are pregnant, or breastfeeding

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026